Want to join the conversation?
$SYK's Orthopaedics sales for 2015 rose 1.7% as reported and 6.7% in constant currency, as FX rates negatively impacted sales by 5%. Excluding 0.5% impact of acquisitions, sales grew 6.1% in constant currency, including 8.6% from higher unit volume and changes in product mix. The rise was led by higher shipments of trauma and extremities products.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.